DaVita (NYSE:DVA) Releases FY 2025 Earnings Guidance

DaVita (NYSE:DVA - Get Free Report) updated its FY 2025 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 10.200-11.300 for the period, compared to the consensus estimate of 11.030. The company issued revenue guidance of -.

Analysts Set New Price Targets

Several equities analysts have recently commented on DVA shares. StockNews.com raised shares of DaVita from a "hold" rating to a "buy" rating in a report on Friday, April 25th. Cowen restated a "hold" rating on shares of DaVita in a report on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a research note on Friday, February 21st. Finally, Barclays increased their price objective on DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a research note on Tuesday, February 18th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, DaVita presently has a consensus rating of "Hold" and a consensus target price of $166.33.

DaVita Trading Up 1.1%

NYSE:DVA traded up $1.63 on Friday, reaching $145.23. The company's stock had a trading volume of 738,898 shares, compared to its average volume of 830,380. The stock has a 50 day moving average price of $145.68 and a 200 day moving average price of $153.48. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. DaVita has a 12-month low of $131.44 and a 12-month high of $179.60. The firm has a market cap of $11.16 billion, a price-to-earnings ratio of 13.52, a price-to-earnings-growth ratio of 1.07 and a beta of 1.14.

DaVita (NYSE:DVA - Get Free Report) last announced its quarterly earnings data on Monday, May 12th. The company reported $2.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.75 by $0.25. The business had revenue of $3.22 billion for the quarter, compared to analysts' expectations of $3.22 billion. DaVita had a return on equity of 115.48% and a net margin of 7.31%. The company's revenue for the quarter was up 5.0% compared to the same quarter last year. During the same period last year, the firm earned $2.26 earnings per share. On average, equities analysts anticipate that DaVita will post 10.76 EPS for the current fiscal year.

Institutional Inflows and Outflows

An institutional investor recently raised its position in DaVita stock. Goldman Sachs Group Inc. boosted its stake in DaVita Inc. (NYSE:DVA - Free Report) by 19.1% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 179,140 shares of the company's stock after buying an additional 28,739 shares during the quarter. Goldman Sachs Group Inc. owned approximately 0.23% of DaVita worth $27,403,000 as of its most recent filing with the SEC. Institutional investors own 90.12% of the company's stock.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.